中国当代医药
中國噹代醫藥
중국당대의약
China Modern Medicine
2015年
29期
58-60
,共3页
戴星%周静%邹志雄%胡鸣%孙玉芳
戴星%週靜%鄒誌雄%鬍鳴%孫玉芳
대성%주정%추지웅%호명%손옥방
子宫肌瘤%促性腺激素释放激素激动剂%腹腔镜子宫肌瘤剔除术
子宮肌瘤%促性腺激素釋放激素激動劑%腹腔鏡子宮肌瘤剔除術
자궁기류%촉성선격소석방격소격동제%복강경자궁기류척제술
Myoma and uterus%Gonadotropin-releasing hormone agonist%Laparoscopic myomectomy
目的:探讨促性腺激素释放激素激动剂(GnRH-a)在子宫体积>孕12周子宫肌瘤患者行腹腔镜子宫肌瘤剥除术前使用的效果。方法选取本院2007年1月~2012年12月收治的25例子宫体积>孕12周的子宫肌瘤患者作为研究对象,术前给予亮丙瑞林皮下注射3针。观察治疗前后子宫及肌瘤体积的改变情况、血红蛋白水平的变化以及术中出血量,随访术后子宫肌瘤的复发情况。结果25例患者治疗后子宫肌瘤体积明显缩小,治疗前B超检查测定的平均体积为(121.7±70.53) cm3,治疗后为(78.3±42.4) cm3,肌瘤体积缩小35.6%,差异有统计学意义(P<0.05)。治疗前的子宫平均体积为(386.9±82.1)cm3,治疗后为(253.5±56.4)cm3,差异有统计学意义(P<0.05)。GnRH-a治疗前的血红蛋白值为(88.7±31.2)g/L,治疗后为(119.3±21.5)g/L,差异有统计学意义(P<0.05)。所有手术均顺利完成,无一例中转开腹。结论术前使用亮丙瑞林3个月,可以显著缩小大子宫肌瘤患者的肌瘤及子宫体积,纠正贫血,减少术中出血,降低术后复发,能够使腹腔镜子宫肌瘤剥除术顺利进行。
目的:探討促性腺激素釋放激素激動劑(GnRH-a)在子宮體積>孕12週子宮肌瘤患者行腹腔鏡子宮肌瘤剝除術前使用的效果。方法選取本院2007年1月~2012年12月收治的25例子宮體積>孕12週的子宮肌瘤患者作為研究對象,術前給予亮丙瑞林皮下註射3針。觀察治療前後子宮及肌瘤體積的改變情況、血紅蛋白水平的變化以及術中齣血量,隨訪術後子宮肌瘤的複髮情況。結果25例患者治療後子宮肌瘤體積明顯縮小,治療前B超檢查測定的平均體積為(121.7±70.53) cm3,治療後為(78.3±42.4) cm3,肌瘤體積縮小35.6%,差異有統計學意義(P<0.05)。治療前的子宮平均體積為(386.9±82.1)cm3,治療後為(253.5±56.4)cm3,差異有統計學意義(P<0.05)。GnRH-a治療前的血紅蛋白值為(88.7±31.2)g/L,治療後為(119.3±21.5)g/L,差異有統計學意義(P<0.05)。所有手術均順利完成,無一例中轉開腹。結論術前使用亮丙瑞林3箇月,可以顯著縮小大子宮肌瘤患者的肌瘤及子宮體積,糾正貧血,減少術中齣血,降低術後複髮,能夠使腹腔鏡子宮肌瘤剝除術順利進行。
목적:탐토촉성선격소석방격소격동제(GnRH-a)재자궁체적>잉12주자궁기류환자행복강경자궁기류박제술전사용적효과。방법선취본원2007년1월~2012년12월수치적25례자궁체적>잉12주적자궁기류환자작위연구대상,술전급여량병서림피하주사3침。관찰치료전후자궁급기류체적적개변정황、혈홍단백수평적변화이급술중출혈량,수방술후자궁기류적복발정황。결과25례환자치료후자궁기류체적명현축소,치료전B초검사측정적평균체적위(121.7±70.53) cm3,치료후위(78.3±42.4) cm3,기류체적축소35.6%,차이유통계학의의(P<0.05)。치료전적자궁평균체적위(386.9±82.1)cm3,치료후위(253.5±56.4)cm3,차이유통계학의의(P<0.05)。GnRH-a치료전적혈홍단백치위(88.7±31.2)g/L,치료후위(119.3±21.5)g/L,차이유통계학의의(P<0.05)。소유수술균순리완성,무일례중전개복。결론술전사용량병서림3개월,가이현저축소대자궁기류환자적기류급자궁체적,규정빈혈,감소술중출혈,강저술후복발,능구사복강경자궁기류박제술순리진행。
Objective To explore the effect of applying gonadotropin-releasing hormone agonist (GnRH-a) before la-paroscopic myomectomy in uterine volume over 12 gestational weeks patients with uterine myoma before myomectomy in large uterus under laparoscope. Methods 25 uterine volume over 12 gestational weeks patients with uterine myoma from January 2007 to December 2012 in our hospital were selected as the research objects.Three-needle leuprolide via subcutaneous injection was used before surgery.The change of volume in uterus and myoma before and after medication were observed.The change of hemoglobin level and intraoperative amount of bleeding were observed and postoperative recurrence of uterus myoma was followed up. Results The volume of uterus myoma after treatment in 25 patients was greatly shortened,the average volume detected by B ultrasound after treatment was (121.7±70.53) cm3,the average vol-ume before treatment was (78.3±42.4) cm3,and the volume of myoma shortened by 35.6%,with significant difference (P<0.05).The average volume of the uterus before treatment was (386.9±82.1) cm3,the average volume of the uterus after treatment was (253.5±56.4) cm3,with significant difference (P<0.05).The hemoglobin value before GnRH-a treatment was (88.7±31.2) g/L,the hemoglobin value after GnRH-a treatment was (119.3±21.5) g/L,with significant difference (P<0.05). The surgeries were all successful,and no case was transferred to laparotomy. Conclusion Application of leuprorelin for 3 months before surgery can greatly shorten volumes of myoma and uterus,correct anemia,reduce postoperative recurrence of uterus myoma and intraoperative amount of bleeding,which ensures smooth performance of laparoscopic myomectomy.